Literature DB >> 7692995

T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes.

R R Voskuhl1, R Martin, C Bergman, M Dalal, N H Ruddle, H F McFarland.   

Abstract

Multiple sclerosis (MS) is widely accepted as an autoimmune disease with myelin basic protein (MBP) a candidate autoantigen. In the current report, human T cell lines specific for an immunodominant region of MBP were shown to have a functional phenotype similar to T helper 1 (Th1) inflammatory cells of the mouse on the basis of their antigen-specific cytotoxic activity and production of interferon-gamma and lymphotoxin/tumor necrosis factor-alpha, but not interleukin-4. In experimental allergic encephalomyelitis (EAE), a proposed animal model for MS, MBP-specific T cell lines which mediate disease are of the Th1 subtype. Thus, MBP-specific T cells in humans exist which are phenotypically similar to MBP-specific encephalitogenic T cells in murine EAE.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692995     DOI: 10.3109/08916939309043888

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  39 in total

1.  miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.

Authors:  Kristen M Smith; Mireia Guerau-de-Arellano; Stefan Costinean; Jessica L Williams; Arianna Bottoni; Gina Mavrikis Cox; Abhay R Satoskar; Carlo M Croce; Michael K Racke; Amy E Lovett-Racke; Caroline C Whitacre
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

2.  Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities.

Authors:  Cassandra E Smith; Stephen D Miller
Journal:  J Autoimmun       Date:  2006-12       Impact factor: 7.094

3.  Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis.

Authors:  Hong Zhang; Joseph R Podojil; Xunrong Luo; Stephen D Miller
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 4.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

Review 5.  Th17 cells in autoimmune diseases.

Authors:  Lei Han; Jing Yang; Xiuwen Wang; Dan Li; Ling Lv; Bin Li
Journal:  Front Med       Date:  2015-02-04       Impact factor: 4.592

Review 6.  Regulation of lymphocyte trafficking in central nervous system autoimmunity.

Authors:  Mohamed Oukka; Estelle Bettelli
Journal:  Curr Opin Immunol       Date:  2018-09-27       Impact factor: 7.486

Review 7.  Oligodendroglial response to the immune cytokine interferon gamma.

Authors:  B Popko; K D Baerwald
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 8.  FLT3 inhibitors for the treatment of autoimmune disease.

Authors:  Katharine A Whartenby; Donald Small; Peter A Calabresi
Journal:  Expert Opin Investig Drugs       Date:  2008-11       Impact factor: 6.206

9.  IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23.

Authors:  Heather M Grifka-Walk; David A Giles; Benjamin M Segal
Journal:  Eur J Immunol       Date:  2015-08-14       Impact factor: 5.532

10.  T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.

Authors:  Yuhong Yang; Jeffrey Weiner; Yue Liu; Alan J Smith; David J Huss; Ryan Winger; Haiyan Peng; Petra D Cravens; Michael K Racke; Amy E Lovett-Racke
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.